NetworkNewsBreaks Archive - Page 1557 of 1657

WednesdayJun 07, 2017 3:31 pm

NetworkNewsBreaks – Cerus Corp. (NASDAQ: CERS) Says FDA Decision Could Minimize Potential PAS Supply Disruption; Shares Higher

Shares of Cerus Corp. (NASDAQ: CERS) are up 11.2% after the biomedical products company said an expected shortage of Fresenius Kabi platelet additive solution (PAS) could be less disruptive to blood center production of INTERCEPT platelets thanks to a key decision by the FDA. The agency is reviewing a recent submission by Fresenius Kabi as a Changes Being Effected in 30 Days (CBE-30) supplement to address some changes in raw materials used by the manufacturer of the PAS container. CBE-30 allows ongoing distribution of the product during the review period, which could minimize impact. “We are cautiously optimistic that a…

WednesdayJun 07, 2017 3:13 pm

NetworkNewsBreaks – Player’s Network (PNTV) Shares Continue Two-Day Streak, Set Second New High this Week

Shares of Player’s Network (OTCQB: PNTV) are up 7% at $0.10 near market close, moving on volume of 5.83 million and setting a new 52-week high for the third time since last Friday. On June 2, PNTV announced (http://nnw.fm/2s34T) that its majority owned Green Leaf Farms subsidiary had completed the first phase of construction for its marijuana cultivation and production facility in North Las Vegas. This achievement was preceded by news earlier in the week that Green Leaf received two Nevada state-issued recreational marijuana licenses, as well as medical marijuana licenses (http://nnw.fm/9XLst). PNTV said the licenses create another revenue stream…

WednesdayJun 07, 2017 12:25 pm

NetworkNewsBreaks – Novavax, Inc. (NASDAQ: NVAX) Announces Publication of Clinical Trial Data in Vaccine

Clinical-stage biotechnology company Novavax, Inc. (NASDAQ: NVAX) today announced that data from the second of two phase II trials of its RSV F protein recombinant nanoparticle vaccine candidate in women of childbearing age have been published in the journal Vaccine. This specific information was previously shared at scientific conferences, and top line results from this trial were originally announced in April 2014. “The Western Blot finding from this trial, which demonstrates a reduction in recent RSV infections of approximately 52% in the vaccine relative to the placebo arms, is consistent with the Western Blot data we reported from a comparable…

WednesdayJun 07, 2017 11:55 am

NetworkNewsBreaks – DragonWave, Inc. (NASDAQ: DRWI) Shares Surge on News of Contract with SmartSky Networks

DragonWave, Inc. (NASDAQ: DRWI), a global supplier of packet microwave radio systems, announced late Tuesday that it has been awarded a product supply and installation services contract from SmartSky Networks, a North American 4G LTE inflight service provider. Under the terms of this deal, SmartSky will deploy DragonWave’s Harmony Enhanced and Harmony Enhanced MC products to provide high-capacity backhaul for its ground to air 4G LTE network. “DragonWave is excited to be working with SmartSky on its innovative high capacity and low latency inflight offering. This application is ideally suited for Harmony Enhanced MC,” Peter Allen, president and CEO of…

WednesdayJun 07, 2017 10:15 am

NetworkNewsBreaks – India Globalization Capital, Inc. (NYSE: IGC) Pursues Clinical Trials of Cannabis-Based Combination Therapies with Assistance of New Advisor

India Globalization Capital (NYSE MKT: IGC) recently named Craig Cheifetz, M.D. as an advisor to assist the company with its clinical trials in microbiology, immunology, neuroscience and biotechnology. IGC CEO Ram Mukunda stated in a news release that the company looks forward to Dr. Cheifetz’s contributions as IGC moves forward in the development of unique cannabis combination therapies. “The company anticipates clinical trials in 2017 for several indications, including pain, a huge market. IGC has already filed for six patents in areas such as eating disorders and epilepsy, in addition to pain. It is working on several more filings for…

TuesdayJun 06, 2017 3:22 pm

NetworkNewsBreaks – Player’s Network, Inc. (PNTV) Rips to New 52-Week High on Quadruple Volume following Series of Corporate Milestones

Shares of Player’s Network (OTCQB: PNTV) are up 25% in today’s late trade, clipping a new 52-week high of $0.093 and moving on volume of 11.91 million – four times the 30-day moving average of 2.78 million. Today’s performance eclipses the 52-week high of $0.075 set at market close on June 2 and continues several days of rallies fueled by a string of corporate achievements. On May 30, PNTV said it received (http://nnw.fm/8AbNW) its medical marijuana licenses, enabling the company to start operations in its 27,000-square-foot facility in North Las Vegas and pushing the stock to the sixth-highest volume on…

TuesdayJun 06, 2017 12:44 pm

NetworkNewsBreaks – Top 10 Mid-day Percentage Gainers on June 6, 2017

Here is a list of stocks shaking up the markets today, with particular focus on NASDAQ and OTC small caps. The top gainers based on percentage: NIHD 36.90% News – Announces partnership with AINMT to invest in Nextel Brazil’s growth EGLT 19.45% News – Obtains coverage of ARYMO® ER (morphine sulfate) extended-release tablets SGLB 5.74% News - Has entered into agreements with two additional, non-exclusive sales agents in the Asia-Pacific region VKTX 4.03% News – Announces positive top line results from a study of VK2809 in an in vivo model of non-alcoholic steatohepatitis (NASH) NK 4.01% News – Expands NANT…

TuesdayJun 06, 2017 12:44 pm

NetworkNewsBreaks – CTI BioPharma Corp. (NASDAQ: CTIC) Prices $45M Offering of Convertible Preferred Stock; Shares Down, but Lift from New 52-Week Low

CTI BioPharma Corp. ("CTI") (NASDAQ: CTIC) this morning priced its underwritten public offering of 22,500 shares of its Series N-3 Preferred Stock at $2,000 per share. The company said it expects gross proceeds from the offering of $45 million. Net proceeds will be used to conduct the PAC203 clinical trial; submit a new Marketing Authorization Application for pacritinib to the European Medicines Agency; conduct additional research concerning the possible application of pacritinib in indications outside of myelofibrosis; and complete the PIX306 clinical trial, as well as for general corporate purposes, which may include funding research and development, conducting preclinical and clinical…

TuesdayJun 06, 2017 11:32 am

NetworkNewsBreaks – NII Holdings, Inc.’s (NASDAQ: NIHD) AINMT Partnership Sends Shares Soaring on Heavy Volume

Shares of NII Holdings (NASDAQ: NIHD) are up more than 40% mid-day on volume of 12.21 million, roughly three times the average 5-day volume, on word the mobile communication services provider has partnered with AINMT Holdings AB ("AINMT"), an international telecommunications company and parent of the Norwegian operator ice, to jointly own and operate Brazilian mobile telecommunications company Nextel Brazil. Per the agreement, AINMT will invest $50 million for a 30% stake in Nextel Holdings S.à r.l. (the "Company"), a wholly owned subsidiary of NII and owner of Nextel Brazil. AINMT has the option to invest an additional $150 million…

TuesdayJun 06, 2017 9:27 am

NetworkNewsBreaks – SinglePoint, Inc. (SING) Teams with First Bitcoin Capital (BITCF) to Develop Bitcoin Payments Solution

Specialized holding company SinglePoint, Inc. (OTC: SING) this morning announced an initiative to develop a bitcoin payments solution in partnership with First Bitcoin Capital Corp. (OTC: BITCF), an industry-leading bitcoin and blockchain technology provider. Per the news release, the two companies have signed a joint venture agreement to develop and distribute a viable payments solution targeted at “high-risk payment verticals including the cannabis industry” in order to “fill the payments gap that currently exists.” Through this new partnership, SinglePoint and First Bitcoin Capital intend to focus on their respective core strengths in order to build and supply the best bitcoin…

Financial news and publishing for public and private companies

Contact us: 212.418.1217

NetworkNewsBreaks